nodes	percent_of_prediction	percent_of_DWPC	metapath
Topiramate—CYP2C19—Rosuvastatin—atherosclerosis	0.0644	0.195	CbGbCtD
Topiramate—CYP2C19—Simvastatin—atherosclerosis	0.0599	0.181	CbGbCtD
Topiramate—CYP2C19—Lovastatin—atherosclerosis	0.0586	0.177	CbGbCtD
Topiramate—CYP3A4—Rosuvastatin—atherosclerosis	0.0311	0.0941	CbGbCtD
Topiramate—CYP3A4—Ezetimibe—atherosclerosis	0.0311	0.0941	CbGbCtD
Topiramate—CYP3A4—Simvastatin—atherosclerosis	0.029	0.0875	CbGbCtD
Topiramate—CYP3A4—Pravastatin—atherosclerosis	0.0283	0.0857	CbGbCtD
Topiramate—CYP3A4—Lovastatin—atherosclerosis	0.0283	0.0857	CbGbCtD
Topiramate—Flatulence—Simvastatin—atherosclerosis	0.000629	0.00134	CcSEcCtD
Topiramate—Tinnitus—Niacin—atherosclerosis	0.000627	0.00134	CcSEcCtD
Topiramate—Erythema multiforme—Pravastatin—atherosclerosis	0.000626	0.00134	CcSEcCtD
Topiramate—Dysgeusia—Simvastatin—atherosclerosis	0.000625	0.00133	CcSEcCtD
Topiramate—Flushing—Niacin—atherosclerosis	0.000624	0.00133	CcSEcCtD
Topiramate—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000621	0.00133	CcSEcCtD
Topiramate—Anaemia—Ezetimibe—atherosclerosis	0.000618	0.00132	CcSEcCtD
Topiramate—Tinnitus—Pravastatin—atherosclerosis	0.000618	0.00132	CcSEcCtD
Topiramate—Malaise—Lovastatin—atherosclerosis	0.000615	0.00131	CcSEcCtD
Topiramate—Flushing—Pravastatin—atherosclerosis	0.000615	0.00131	CcSEcCtD
Topiramate—Cardiac disorder—Pravastatin—atherosclerosis	0.000615	0.00131	CcSEcCtD
Topiramate—Muscle spasms—Simvastatin—atherosclerosis	0.000613	0.00131	CcSEcCtD
Topiramate—Vertigo—Lovastatin—atherosclerosis	0.000613	0.00131	CcSEcCtD
Topiramate—Angiopathy—Niacin—atherosclerosis	0.00061	0.0013	CcSEcCtD
Topiramate—Leukopenia—Lovastatin—atherosclerosis	0.00061	0.0013	CcSEcCtD
Topiramate—Chills—Niacin—atherosclerosis	0.000604	0.00129	CcSEcCtD
Topiramate—Malaise—Ezetimibe—atherosclerosis	0.000603	0.00129	CcSEcCtD
Topiramate—Vision blurred—Simvastatin—atherosclerosis	0.000601	0.00128	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000598	0.00128	CcSEcCtD
Topiramate—Tremor—Simvastatin—atherosclerosis	0.000598	0.00128	CcSEcCtD
Topiramate—Alopecia—Niacin—atherosclerosis	0.000595	0.00127	CcSEcCtD
Topiramate—Chills—Pravastatin—atherosclerosis	0.000594	0.00127	CcSEcCtD
Topiramate—Insomnia—Rosuvastatin—atherosclerosis	0.000594	0.00127	CcSEcCtD
Topiramate—Ill-defined disorder—Simvastatin—atherosclerosis	0.000592	0.00126	CcSEcCtD
Topiramate—Palpitations—Ezetimibe—atherosclerosis	0.000591	0.00126	CcSEcCtD
Topiramate—Paraesthesia—Rosuvastatin—atherosclerosis	0.00059	0.00126	CcSEcCtD
Topiramate—Anaemia—Simvastatin—atherosclerosis	0.00059	0.00126	CcSEcCtD
Topiramate—Malnutrition—Niacin—atherosclerosis	0.000586	0.00125	CcSEcCtD
Topiramate—Erythema—Niacin—atherosclerosis	0.000586	0.00125	CcSEcCtD
Topiramate—Alopecia—Pravastatin—atherosclerosis	0.000585	0.00125	CcSEcCtD
Topiramate—Cough—Ezetimibe—atherosclerosis	0.000584	0.00125	CcSEcCtD
Topiramate—Chest pain—Lovastatin—atherosclerosis	0.000581	0.00124	CcSEcCtD
Topiramate—Arthralgia—Lovastatin—atherosclerosis	0.000581	0.00124	CcSEcCtD
Topiramate—Myalgia—Lovastatin—atherosclerosis	0.000581	0.00124	CcSEcCtD
Topiramate—Anxiety—Lovastatin—atherosclerosis	0.000579	0.00124	CcSEcCtD
Topiramate—Dyspepsia—Rosuvastatin—atherosclerosis	0.000578	0.00123	CcSEcCtD
Topiramate—Hypertension—Ezetimibe—atherosclerosis	0.000577	0.00123	CcSEcCtD
Topiramate—Flatulence—Niacin—atherosclerosis	0.000577	0.00123	CcSEcCtD
Topiramate—Malaise—Simvastatin—atherosclerosis	0.000575	0.00123	CcSEcCtD
Topiramate—Tension—Niacin—atherosclerosis	0.000575	0.00123	CcSEcCtD
Topiramate—Discomfort—Lovastatin—atherosclerosis	0.000574	0.00123	CcSEcCtD
Topiramate—Vertigo—Simvastatin—atherosclerosis	0.000573	0.00122	CcSEcCtD
Topiramate—Leukopenia—Simvastatin—atherosclerosis	0.000571	0.00122	CcSEcCtD
Topiramate—Chest pain—Ezetimibe—atherosclerosis	0.000569	0.00122	CcSEcCtD
Topiramate—Arthralgia—Ezetimibe—atherosclerosis	0.000569	0.00122	CcSEcCtD
Topiramate—Myalgia—Ezetimibe—atherosclerosis	0.000569	0.00122	CcSEcCtD
Topiramate—Nervousness—Niacin—atherosclerosis	0.000569	0.00122	CcSEcCtD
Topiramate—Flatulence—Pravastatin—atherosclerosis	0.000568	0.00121	CcSEcCtD
Topiramate—Dry mouth—Lovastatin—atherosclerosis	0.000568	0.00121	CcSEcCtD
Topiramate—Tension—Pravastatin—atherosclerosis	0.000566	0.00121	CcSEcCtD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000566	0.00121	CcSEcCtD
Topiramate—Dysgeusia—Pravastatin—atherosclerosis	0.000565	0.00121	CcSEcCtD
Topiramate—Muscle spasms—Niacin—atherosclerosis	0.000563	0.0012	CcSEcCtD
Topiramate—Discomfort—Ezetimibe—atherosclerosis	0.000563	0.0012	CcSEcCtD
Topiramate—Constipation—Rosuvastatin—atherosclerosis	0.000562	0.0012	CcSEcCtD
Topiramate—Pain—Rosuvastatin—atherosclerosis	0.000562	0.0012	CcSEcCtD
Topiramate—Confusional state—Lovastatin—atherosclerosis	0.000561	0.0012	CcSEcCtD
Topiramate—Nervousness—Pravastatin—atherosclerosis	0.00056	0.0012	CcSEcCtD
Topiramate—Dry mouth—Ezetimibe—atherosclerosis	0.000557	0.00119	CcSEcCtD
Topiramate—Muscle spasms—Pravastatin—atherosclerosis	0.000554	0.00118	CcSEcCtD
Topiramate—Infection—Lovastatin—atherosclerosis	0.000553	0.00118	CcSEcCtD
Topiramate—Vision blurred—Niacin—atherosclerosis	0.000552	0.00118	CcSEcCtD
Topiramate—Confusional state—Ezetimibe—atherosclerosis	0.00055	0.00118	CcSEcCtD
Topiramate—Thrombocytopenia—Lovastatin—atherosclerosis	0.000545	0.00116	CcSEcCtD
Topiramate—Vision blurred—Pravastatin—atherosclerosis	0.000544	0.00116	CcSEcCtD
Topiramate—Myalgia—Simvastatin—atherosclerosis	0.000543	0.00116	CcSEcCtD
Topiramate—Arthralgia—Simvastatin—atherosclerosis	0.000543	0.00116	CcSEcCtD
Topiramate—Chest pain—Simvastatin—atherosclerosis	0.000543	0.00116	CcSEcCtD
Topiramate—Infection—Ezetimibe—atherosclerosis	0.000542	0.00116	CcSEcCtD
Topiramate—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000541	0.00116	CcSEcCtD
Topiramate—Anxiety—Simvastatin—atherosclerosis	0.000541	0.00116	CcSEcCtD
Topiramate—Tremor—Pravastatin—atherosclerosis	0.00054	0.00115	CcSEcCtD
Topiramate—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000537	0.00115	CcSEcCtD
Topiramate—Discomfort—Simvastatin—atherosclerosis	0.000537	0.00115	CcSEcCtD
Topiramate—Nervous system disorder—Ezetimibe—atherosclerosis	0.000535	0.00114	CcSEcCtD
Topiramate—Ill-defined disorder—Pravastatin—atherosclerosis	0.000535	0.00114	CcSEcCtD
Topiramate—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000535	0.00114	CcSEcCtD
Topiramate—Anaemia—Pravastatin—atherosclerosis	0.000533	0.00114	CcSEcCtD
Topiramate—Anorexia—Lovastatin—atherosclerosis	0.000531	0.00113	CcSEcCtD
Topiramate—Skin disorder—Ezetimibe—atherosclerosis	0.00053	0.00113	CcSEcCtD
Topiramate—Vertigo—Niacin—atherosclerosis	0.000526	0.00112	CcSEcCtD
Topiramate—Syncope—Niacin—atherosclerosis	0.000525	0.00112	CcSEcCtD
Topiramate—Confusional state—Simvastatin—atherosclerosis	0.000525	0.00112	CcSEcCtD
Topiramate—Leukopenia—Niacin—atherosclerosis	0.000524	0.00112	CcSEcCtD
Topiramate—Urticaria—Rosuvastatin—atherosclerosis	0.000522	0.00111	CcSEcCtD
Topiramate—Oedema—Simvastatin—atherosclerosis	0.000521	0.00111	CcSEcCtD
Topiramate—Malaise—Pravastatin—atherosclerosis	0.00052	0.00111	CcSEcCtD
Topiramate—Abdominal pain—Rosuvastatin—atherosclerosis	0.000519	0.00111	CcSEcCtD
Topiramate—Vertigo—Pravastatin—atherosclerosis	0.000518	0.00111	CcSEcCtD
Topiramate—Palpitations—Niacin—atherosclerosis	0.000518	0.00111	CcSEcCtD
Topiramate—Infection—Simvastatin—atherosclerosis	0.000517	0.0011	CcSEcCtD
Topiramate—Leukopenia—Pravastatin—atherosclerosis	0.000516	0.0011	CcSEcCtD
Topiramate—Loss of consciousness—Niacin—atherosclerosis	0.000515	0.0011	CcSEcCtD
Topiramate—Cough—Niacin—atherosclerosis	0.000511	0.00109	CcSEcCtD
Topiramate—Thrombocytopenia—Simvastatin—atherosclerosis	0.00051	0.00109	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000507	0.00108	CcSEcCtD
Topiramate—Insomnia—Lovastatin—atherosclerosis	0.000503	0.00108	CcSEcCtD
Topiramate—Cough—Pravastatin—atherosclerosis	0.000503	0.00107	CcSEcCtD
Topiramate—Paraesthesia—Lovastatin—atherosclerosis	0.0005	0.00107	CcSEcCtD
Topiramate—Myalgia—Niacin—atherosclerosis	0.000499	0.00107	CcSEcCtD
Topiramate—Arthralgia—Niacin—atherosclerosis	0.000499	0.00107	CcSEcCtD
Topiramate—Hypertension—Pravastatin—atherosclerosis	0.000498	0.00106	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000497	0.00106	CcSEcCtD
Topiramate—Anorexia—Simvastatin—atherosclerosis	0.000496	0.00106	CcSEcCtD
Topiramate—Dyspnoea—Lovastatin—atherosclerosis	0.000496	0.00106	CcSEcCtD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000495	0.00106	CcSEcCtD
Topiramate—Insomnia—Ezetimibe—atherosclerosis	0.000494	0.00105	CcSEcCtD
Topiramate—Arthralgia—Pravastatin—atherosclerosis	0.000491	0.00105	CcSEcCtD
Topiramate—Chest pain—Pravastatin—atherosclerosis	0.000491	0.00105	CcSEcCtD
Topiramate—Myalgia—Pravastatin—atherosclerosis	0.000491	0.00105	CcSEcCtD
Topiramate—Paraesthesia—Ezetimibe—atherosclerosis	0.00049	0.00105	CcSEcCtD
Topiramate—Dyspepsia—Lovastatin—atherosclerosis	0.00049	0.00105	CcSEcCtD
Topiramate—Anxiety—Pravastatin—atherosclerosis	0.000489	0.00105	CcSEcCtD
Topiramate—Dry mouth—Niacin—atherosclerosis	0.000488	0.00104	CcSEcCtD
Topiramate—Dyspnoea—Ezetimibe—atherosclerosis	0.000487	0.00104	CcSEcCtD
Topiramate—Discomfort—Pravastatin—atherosclerosis	0.000485	0.00104	CcSEcCtD
Topiramate—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000484	0.00103	CcSEcCtD
Topiramate—Decreased appetite—Lovastatin—atherosclerosis	0.000484	0.00103	CcSEcCtD
Topiramate—Dyspepsia—Ezetimibe—atherosclerosis	0.000481	0.00103	CcSEcCtD
Topiramate—Fatigue—Lovastatin—atherosclerosis	0.00048	0.00102	CcSEcCtD
Topiramate—Oedema—Niacin—atherosclerosis	0.000478	0.00102	CcSEcCtD
Topiramate—Pain—Lovastatin—atherosclerosis	0.000476	0.00102	CcSEcCtD
Topiramate—Constipation—Lovastatin—atherosclerosis	0.000476	0.00102	CcSEcCtD
Topiramate—Confusional state—Pravastatin—atherosclerosis	0.000475	0.00101	CcSEcCtD
Topiramate—Decreased appetite—Ezetimibe—atherosclerosis	0.000475	0.00101	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000474	0.00101	CcSEcCtD
Topiramate—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000471	0.00101	CcSEcCtD
Topiramate—Asthenia—Rosuvastatin—atherosclerosis	0.000471	0.00101	CcSEcCtD
Topiramate—Insomnia—Simvastatin—atherosclerosis	0.000471	0.00101	CcSEcCtD
Topiramate—Oedema—Pravastatin—atherosclerosis	0.000471	0.00101	CcSEcCtD
Topiramate—Fatigue—Ezetimibe—atherosclerosis	0.000471	0.00101	CcSEcCtD
Topiramate—Shock—Niacin—atherosclerosis	0.00047	0.001	CcSEcCtD
Topiramate—Infection—Pravastatin—atherosclerosis	0.000468	0.000999	CcSEcCtD
Topiramate—Paraesthesia—Simvastatin—atherosclerosis	0.000467	0.000998	CcSEcCtD
Topiramate—Pain—Ezetimibe—atherosclerosis	0.000467	0.000997	CcSEcCtD
Topiramate—Constipation—Ezetimibe—atherosclerosis	0.000467	0.000997	CcSEcCtD
Topiramate—Tachycardia—Niacin—atherosclerosis	0.000467	0.000996	CcSEcCtD
Topiramate—Pruritus—Rosuvastatin—atherosclerosis	0.000465	0.000992	CcSEcCtD
Topiramate—Skin disorder—Niacin—atherosclerosis	0.000464	0.000992	CcSEcCtD
Topiramate—Dyspnoea—Simvastatin—atherosclerosis	0.000464	0.000991	CcSEcCtD
Topiramate—Hyperhidrosis—Niacin—atherosclerosis	0.000462	0.000987	CcSEcCtD
Topiramate—Thrombocytopenia—Pravastatin—atherosclerosis	0.000461	0.000984	CcSEcCtD
Topiramate—Feeling abnormal—Lovastatin—atherosclerosis	0.000459	0.00098	CcSEcCtD
Topiramate—Dyspepsia—Simvastatin—atherosclerosis	0.000458	0.000979	CcSEcCtD
Topiramate—Anorexia—Niacin—atherosclerosis	0.000456	0.000973	CcSEcCtD
Topiramate—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000455	0.000972	CcSEcCtD
Topiramate—Hyperhidrosis—Pravastatin—atherosclerosis	0.000455	0.000972	CcSEcCtD
Topiramate—Decreased appetite—Simvastatin—atherosclerosis	0.000453	0.000967	CcSEcCtD
Topiramate—Feeling abnormal—Ezetimibe—atherosclerosis	0.00045	0.000961	CcSEcCtD
Topiramate—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000449	0.00096	CcSEcCtD
Topiramate—Diarrhoea—Rosuvastatin—atherosclerosis	0.000449	0.00096	CcSEcCtD
Topiramate—Fatigue—Simvastatin—atherosclerosis	0.000449	0.000959	CcSEcCtD
Topiramate—Anorexia—Pravastatin—atherosclerosis	0.000449	0.000958	CcSEcCtD
Topiramate—Hypotension—Niacin—atherosclerosis	0.000447	0.000954	CcSEcCtD
Topiramate—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000446	0.000953	CcSEcCtD
Topiramate—Pain—Simvastatin—atherosclerosis	0.000445	0.000951	CcSEcCtD
Topiramate—Constipation—Simvastatin—atherosclerosis	0.000445	0.000951	CcSEcCtD
Topiramate—Urticaria—Lovastatin—atherosclerosis	0.000442	0.000944	CcSEcCtD
Topiramate—Abdominal pain—Lovastatin—atherosclerosis	0.00044	0.00094	CcSEcCtD
Topiramate—Body temperature increased—Lovastatin—atherosclerosis	0.00044	0.00094	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000436	0.00093	CcSEcCtD
Topiramate—Dizziness—Rosuvastatin—atherosclerosis	0.000434	0.000928	CcSEcCtD
Topiramate—Urticaria—Ezetimibe—atherosclerosis	0.000434	0.000926	CcSEcCtD
Topiramate—Insomnia—Niacin—atherosclerosis	0.000432	0.000923	CcSEcCtD
Topiramate—Body temperature increased—Ezetimibe—atherosclerosis	0.000432	0.000922	CcSEcCtD
Topiramate—Abdominal pain—Ezetimibe—atherosclerosis	0.000432	0.000922	CcSEcCtD
Topiramate—Paraesthesia—Niacin—atherosclerosis	0.000429	0.000917	CcSEcCtD
Topiramate—Feeling abnormal—Simvastatin—atherosclerosis	0.000429	0.000916	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000429	0.000916	CcSEcCtD
Topiramate—Dyspnoea—Niacin—atherosclerosis	0.000426	0.00091	CcSEcCtD
Topiramate—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000426	0.000909	CcSEcCtD
Topiramate—Insomnia—Pravastatin—atherosclerosis	0.000426	0.000909	CcSEcCtD
Topiramate—Somnolence—Niacin—atherosclerosis	0.000425	0.000908	CcSEcCtD
Topiramate—Paraesthesia—Pravastatin—atherosclerosis	0.000423	0.000903	CcSEcCtD
Topiramate—Dyspepsia—Niacin—atherosclerosis	0.000421	0.000899	CcSEcCtD
Topiramate—Dyspnoea—Pravastatin—atherosclerosis	0.00042	0.000896	CcSEcCtD
Topiramate—Decreased appetite—Niacin—atherosclerosis	0.000416	0.000888	CcSEcCtD
Topiramate—Dyspepsia—Pravastatin—atherosclerosis	0.000414	0.000885	CcSEcCtD
Topiramate—Rash—Rosuvastatin—atherosclerosis	0.000414	0.000884	CcSEcCtD
Topiramate—Dermatitis—Rosuvastatin—atherosclerosis	0.000414	0.000884	CcSEcCtD
Topiramate—Urticaria—Simvastatin—atherosclerosis	0.000414	0.000883	CcSEcCtD
Topiramate—Gastrointestinal disorder—Niacin—atherosclerosis	0.000413	0.000881	CcSEcCtD
Topiramate—Abdominal pain—Simvastatin—atherosclerosis	0.000412	0.000879	CcSEcCtD
Topiramate—Body temperature increased—Simvastatin—atherosclerosis	0.000412	0.000879	CcSEcCtD
Topiramate—Headache—Rosuvastatin—atherosclerosis	0.000411	0.000879	CcSEcCtD
Topiramate—Hypersensitivity—Lovastatin—atherosclerosis	0.00041	0.000876	CcSEcCtD
Topiramate—Decreased appetite—Pravastatin—atherosclerosis	0.000409	0.000874	CcSEcCtD
Topiramate—Pain—Niacin—atherosclerosis	0.000409	0.000873	CcSEcCtD
Topiramate—Fatigue—Pravastatin—atherosclerosis	0.000406	0.000867	CcSEcCtD
Topiramate—Pain—Pravastatin—atherosclerosis	0.000402	0.00086	CcSEcCtD
Topiramate—Constipation—Pravastatin—atherosclerosis	0.000402	0.00086	CcSEcCtD
Topiramate—Hypersensitivity—Ezetimibe—atherosclerosis	0.000402	0.000859	CcSEcCtD
Topiramate—Asthenia—Lovastatin—atherosclerosis	0.000399	0.000853	CcSEcCtD
Topiramate—Pruritus—Lovastatin—atherosclerosis	0.000394	0.000841	CcSEcCtD
Topiramate—Asthenia—Ezetimibe—atherosclerosis	0.000392	0.000837	CcSEcCtD
Topiramate—Gastrointestinal pain—Niacin—atherosclerosis	0.000391	0.000835	CcSEcCtD
Topiramate—Nausea—Rosuvastatin—atherosclerosis	0.00039	0.000833	CcSEcCtD
Topiramate—Feeling abnormal—Pravastatin—atherosclerosis	0.000388	0.000828	CcSEcCtD
Topiramate—Pruritus—Ezetimibe—atherosclerosis	0.000386	0.000825	CcSEcCtD
Topiramate—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000385	0.000822	CcSEcCtD
Topiramate—Hypersensitivity—Simvastatin—atherosclerosis	0.000384	0.000819	CcSEcCtD
Topiramate—Diarrhoea—Lovastatin—atherosclerosis	0.000381	0.000813	CcSEcCtD
Topiramate—Urticaria—Niacin—atherosclerosis	0.00038	0.000811	CcSEcCtD
Topiramate—Abdominal pain—Niacin—atherosclerosis	0.000378	0.000807	CcSEcCtD
Topiramate—Body temperature increased—Niacin—atherosclerosis	0.000378	0.000807	CcSEcCtD
Topiramate—Urticaria—Pravastatin—atherosclerosis	0.000374	0.000799	CcSEcCtD
Topiramate—Asthenia—Simvastatin—atherosclerosis	0.000374	0.000798	CcSEcCtD
Topiramate—Diarrhoea—Ezetimibe—atherosclerosis	0.000374	0.000798	CcSEcCtD
Topiramate—Abdominal pain—Pravastatin—atherosclerosis	0.000372	0.000795	CcSEcCtD
Topiramate—Body temperature increased—Pravastatin—atherosclerosis	0.000372	0.000795	CcSEcCtD
Topiramate—Pruritus—Simvastatin—atherosclerosis	0.000368	0.000787	CcSEcCtD
Topiramate—Dizziness—Lovastatin—atherosclerosis	0.000368	0.000786	CcSEcCtD
Topiramate—Dizziness—Ezetimibe—atherosclerosis	0.000361	0.000771	CcSEcCtD
Topiramate—Diarrhoea—Simvastatin—atherosclerosis	0.000356	0.000761	CcSEcCtD
Topiramate—Vomiting—Lovastatin—atherosclerosis	0.000354	0.000756	CcSEcCtD
Topiramate—Hypersensitivity—Niacin—atherosclerosis	0.000352	0.000752	CcSEcCtD
Topiramate—Rash—Lovastatin—atherosclerosis	0.000351	0.00075	CcSEcCtD
Topiramate—Dermatitis—Lovastatin—atherosclerosis	0.000351	0.000749	CcSEcCtD
Topiramate—Headache—Lovastatin—atherosclerosis	0.000349	0.000745	CcSEcCtD
Topiramate—Vomiting—Ezetimibe—atherosclerosis	0.000347	0.000741	CcSEcCtD
Topiramate—Hypersensitivity—Pravastatin—atherosclerosis	0.000347	0.000741	CcSEcCtD
Topiramate—Dizziness—Simvastatin—atherosclerosis	0.000344	0.000735	CcSEcCtD
Topiramate—Rash—Ezetimibe—atherosclerosis	0.000344	0.000735	CcSEcCtD
Topiramate—Dermatitis—Ezetimibe—atherosclerosis	0.000344	0.000734	CcSEcCtD
Topiramate—Asthenia—Niacin—atherosclerosis	0.000343	0.000733	CcSEcCtD
Topiramate—Headache—Ezetimibe—atherosclerosis	0.000342	0.00073	CcSEcCtD
Topiramate—Pruritus—Niacin—atherosclerosis	0.000338	0.000722	CcSEcCtD
Topiramate—Asthenia—Pravastatin—atherosclerosis	0.000338	0.000721	CcSEcCtD
Topiramate—Pruritus—Pravastatin—atherosclerosis	0.000333	0.000711	CcSEcCtD
Topiramate—Vomiting—Simvastatin—atherosclerosis	0.000331	0.000707	CcSEcCtD
Topiramate—Nausea—Lovastatin—atherosclerosis	0.000331	0.000706	CcSEcCtD
Topiramate—Rash—Simvastatin—atherosclerosis	0.000328	0.000701	CcSEcCtD
Topiramate—Dermatitis—Simvastatin—atherosclerosis	0.000328	0.0007	CcSEcCtD
Topiramate—Diarrhoea—Niacin—atherosclerosis	0.000327	0.000699	CcSEcCtD
Topiramate—Headache—Simvastatin—atherosclerosis	0.000326	0.000697	CcSEcCtD
Topiramate—Nausea—Ezetimibe—atherosclerosis	0.000324	0.000693	CcSEcCtD
Topiramate—Diarrhoea—Pravastatin—atherosclerosis	0.000322	0.000688	CcSEcCtD
Topiramate—Dizziness—Niacin—atherosclerosis	0.000316	0.000675	CcSEcCtD
Topiramate—Dizziness—Pravastatin—atherosclerosis	0.000311	0.000665	CcSEcCtD
Topiramate—Nausea—Simvastatin—atherosclerosis	0.000309	0.00066	CcSEcCtD
Topiramate—Vomiting—Niacin—atherosclerosis	0.000304	0.000649	CcSEcCtD
Topiramate—Rash—Niacin—atherosclerosis	0.000301	0.000644	CcSEcCtD
Topiramate—Dermatitis—Niacin—atherosclerosis	0.000301	0.000643	CcSEcCtD
Topiramate—Headache—Niacin—atherosclerosis	0.000299	0.00064	CcSEcCtD
Topiramate—Vomiting—Pravastatin—atherosclerosis	0.000299	0.000639	CcSEcCtD
Topiramate—Rash—Pravastatin—atherosclerosis	0.000297	0.000634	CcSEcCtD
Topiramate—Dermatitis—Pravastatin—atherosclerosis	0.000296	0.000633	CcSEcCtD
Topiramate—Headache—Pravastatin—atherosclerosis	0.000295	0.00063	CcSEcCtD
Topiramate—Nausea—Niacin—atherosclerosis	0.000284	0.000606	CcSEcCtD
Topiramate—Nausea—Pravastatin—atherosclerosis	0.00028	0.000597	CcSEcCtD
Topiramate—CA6—Metabolism—INS—atherosclerosis	5.44e-05	0.000271	CbGpPWpGaD
Topiramate—CA9—Metabolism—ABCA1—atherosclerosis	5.4e-05	0.000269	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	5.39e-05	0.000268	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PIK3CG—atherosclerosis	5.37e-05	0.000267	CbGpPWpGaD
Topiramate—CA7—Metabolism—PIK3CG—atherosclerosis	5.37e-05	0.000267	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—MAPK3—atherosclerosis	5.36e-05	0.000267	CbGpPWpGaD
Topiramate—CA4—Metabolism—GSTM1—atherosclerosis	5.34e-05	0.000266	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—MAPK3—atherosclerosis	5.28e-05	0.000263	CbGpPWpGaD
Topiramate—CA1—Metabolism—HMOX1—atherosclerosis	5.27e-05	0.000262	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	5.27e-05	0.000262	CbGpPWpGaD
Topiramate—CA2—Metabolism—APOB—atherosclerosis	5.27e-05	0.000262	CbGpPWpGaD
Topiramate—CA4—Metabolism—LPL—atherosclerosis	5.24e-05	0.000261	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—TGFB1—atherosclerosis	5.2e-05	0.000259	CbGpPWpGaD
Topiramate—CA7—Metabolism—PPARG—atherosclerosis	5.18e-05	0.000258	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PPARG—atherosclerosis	5.18e-05	0.000258	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—APOB—atherosclerosis	5.16e-05	0.000257	CbGpPWpGaD
Topiramate—CA2—Metabolism—GSTM1—atherosclerosis	5.12e-05	0.000255	CbGpPWpGaD
Topiramate—CA4—Metabolism—GPX1—atherosclerosis	5.12e-05	0.000255	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—APOA1—atherosclerosis	5.11e-05	0.000254	CbGpPWpGaD
Topiramate—CA5B—Metabolism—INS—atherosclerosis	5.08e-05	0.000253	CbGpPWpGaD
Topiramate—CA7—Metabolism—INS—atherosclerosis	5.08e-05	0.000253	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	5.07e-05	0.000252	CbGpPWpGaD
Topiramate—CA1—Metabolism—APOB—atherosclerosis	5.05e-05	0.000251	CbGpPWpGaD
Topiramate—CA2—Metabolism—LPL—atherosclerosis	5.03e-05	0.00025	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—LDLRAP1—atherosclerosis	5.01e-05	0.000249	CbGpPWpGaD
Topiramate—CA5A—Metabolism—ALB—atherosclerosis	4.99e-05	0.000248	CbGpPWpGaD
Topiramate—CA6—Metabolism—ALB—atherosclerosis	4.99e-05	0.000248	CbGpPWpGaD
Topiramate—CA4—Metabolism—CD36—atherosclerosis	4.98e-05	0.000248	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—PPARA—atherosclerosis	4.98e-05	0.000248	CbGpPWpGaD
Topiramate—CA12—Metabolism—PIK3CG—atherosclerosis	4.97e-05	0.000248	CbGpPWpGaD
Topiramate—CA1—Metabolism—GSTM1—atherosclerosis	4.91e-05	0.000244	CbGpPWpGaD
Topiramate—CA2—Metabolism—GPX1—atherosclerosis	4.91e-05	0.000244	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	4.9e-05	0.000244	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—TNF—atherosclerosis	4.86e-05	0.000242	CbGpPWpGaD
Topiramate—CA1—Metabolism—LPL—atherosclerosis	4.82e-05	0.00024	CbGpPWpGaD
Topiramate—CA12—Metabolism—PPARG—atherosclerosis	4.8e-05	0.000239	CbGpPWpGaD
Topiramate—CA2—Metabolism—CD36—atherosclerosis	4.78e-05	0.000238	CbGpPWpGaD
Topiramate—CA6—Metabolism—NOS3—atherosclerosis	4.77e-05	0.000238	CbGpPWpGaD
Topiramate—CA5A—Metabolism—NOS3—atherosclerosis	4.77e-05	0.000238	CbGpPWpGaD
Topiramate—CA4—Metabolism—MTHFR—atherosclerosis	4.72e-05	0.000235	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PLTP—atherosclerosis	4.71e-05	0.000234	CbGpPWpGaD
Topiramate—CA12—Metabolism—INS—atherosclerosis	4.71e-05	0.000234	CbGpPWpGaD
Topiramate—CA1—Metabolism—GPX1—atherosclerosis	4.7e-05	0.000234	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—APOA1—atherosclerosis	4.67e-05	0.000233	CbGpPWpGaD
Topiramate—CA7—Metabolism—ALB—atherosclerosis	4.66e-05	0.000232	CbGpPWpGaD
Topiramate—CA5B—Metabolism—ALB—atherosclerosis	4.66e-05	0.000232	CbGpPWpGaD
Topiramate—CA9—Metabolism—HMOX1—atherosclerosis	4.63e-05	0.000231	CbGpPWpGaD
Topiramate—CA4—Metabolism—PPARA—atherosclerosis	4.63e-05	0.000231	CbGpPWpGaD
Topiramate—CA1—Metabolism—CD36—atherosclerosis	4.58e-05	0.000228	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—IL6—atherosclerosis	4.57e-05	0.000227	CbGpPWpGaD
Topiramate—CA2—Metabolism—MTHFR—atherosclerosis	4.53e-05	0.000225	CbGpPWpGaD
Topiramate—CA4—Metabolism—AGT—atherosclerosis	4.49e-05	0.000223	CbGpPWpGaD
Topiramate—CA5B—Metabolism—NOS3—atherosclerosis	4.46e-05	0.000222	CbGpPWpGaD
Topiramate—CA7—Metabolism—NOS3—atherosclerosis	4.46e-05	0.000222	CbGpPWpGaD
Topiramate—CA2—Metabolism—PPARA—atherosclerosis	4.44e-05	0.000221	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—MMP9—atherosclerosis	4.44e-05	0.000221	CbGpPWpGaD
Topiramate—CA9—Metabolism—APOB—atherosclerosis	4.44e-05	0.000221	CbGpPWpGaD
Topiramate—CA4—Metabolism—APOE—atherosclerosis	4.4e-05	0.000219	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—NFKB1—atherosclerosis	4.39e-05	0.000219	CbGpPWpGaD
Topiramate—CA5A—Metabolism—PTGS2—atherosclerosis	4.37e-05	0.000217	CbGpPWpGaD
Topiramate—CA6—Metabolism—PTGS2—atherosclerosis	4.37e-05	0.000217	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	4.36e-05	0.000217	CbGpPWpGaD
Topiramate—CA4—Metabolism—CAV1—atherosclerosis	4.36e-05	0.000217	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—PPARA—atherosclerosis	4.35e-05	0.000217	CbGpPWpGaD
Topiramate—CA4—Metabolism—APOA1—atherosclerosis	4.35e-05	0.000216	CbGpPWpGaD
Topiramate—CA1—Metabolism—MTHFR—atherosclerosis	4.34e-05	0.000216	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	4.34e-05	0.000216	CbGpPWpGaD
Topiramate—CA9—Metabolism—GSTM1—atherosclerosis	4.32e-05	0.000215	CbGpPWpGaD
Topiramate—CA12—Metabolism—ALB—atherosclerosis	4.32e-05	0.000215	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	4.31e-05	0.000215	CbGpPWpGaD
Topiramate—CA2—Metabolism—AGT—atherosclerosis	4.3e-05	0.000214	CbGpPWpGaD
Topiramate—CA1—Metabolism—PPARA—atherosclerosis	4.26e-05	0.000212	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	4.25e-05	0.000211	CbGpPWpGaD
Topiramate—CA9—Metabolism—LPL—atherosclerosis	4.24e-05	0.000211	CbGpPWpGaD
Topiramate—CA2—Metabolism—APOE—atherosclerosis	4.21e-05	0.00021	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	4.21e-05	0.00021	CbGpPWpGaD
Topiramate—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	4.19e-05	0.000209	CbGpPWpGaD
Topiramate—CA2—Metabolism—CAV1—atherosclerosis	4.18e-05	0.000208	CbGpPWpGaD
Topiramate—CA2—Metabolism—APOA1—atherosclerosis	4.17e-05	0.000207	CbGpPWpGaD
Topiramate—CA9—Metabolism—GPX1—atherosclerosis	4.13e-05	0.000206	CbGpPWpGaD
Topiramate—CA12—Metabolism—NOS3—atherosclerosis	4.13e-05	0.000205	CbGpPWpGaD
Topiramate—CA1—Metabolism—AGT—atherosclerosis	4.12e-05	0.000205	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ABCG8—atherosclerosis	4.08e-05	0.000203	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—LTA4H—atherosclerosis	4.08e-05	0.000203	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—APOA1—atherosclerosis	4.08e-05	0.000203	CbGpPWpGaD
Topiramate—CA7—Metabolism—PTGS2—atherosclerosis	4.08e-05	0.000203	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PTGS2—atherosclerosis	4.08e-05	0.000203	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—ALB—atherosclerosis	4.05e-05	0.000201	CbGpPWpGaD
Topiramate—CA1—Metabolism—APOE—atherosclerosis	4.04e-05	0.000201	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	4.03e-05	0.000201	CbGpPWpGaD
Topiramate—CA9—Metabolism—CD36—atherosclerosis	4.03e-05	0.0002	CbGpPWpGaD
Topiramate—CA1—Metabolism—CAV1—atherosclerosis	4e-05	0.000199	CbGpPWpGaD
Topiramate—CA1—Metabolism—APOA1—atherosclerosis	3.99e-05	0.000199	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—VEGFA—atherosclerosis	3.99e-05	0.000198	CbGpPWpGaD
Topiramate—CA4—Metabolism—PIK3CG—atherosclerosis	3.97e-05	0.000197	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—STAT3—atherosclerosis	3.95e-05	0.000196	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—IL6—atherosclerosis	3.92e-05	0.000195	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—IL6—atherosclerosis	3.86e-05	0.000192	CbGpPWpGaD
Topiramate—CA4—Metabolism—PPARG—atherosclerosis	3.83e-05	0.000191	CbGpPWpGaD
Topiramate—CA9—Metabolism—MTHFR—atherosclerosis	3.82e-05	0.00019	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	3.81e-05	0.00019	CbGpPWpGaD
Topiramate—CA2—Metabolism—PIK3CG—atherosclerosis	3.8e-05	0.000189	CbGpPWpGaD
Topiramate—CA12—Metabolism—PTGS2—atherosclerosis	3.78e-05	0.000188	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—MAPK3—atherosclerosis	3.77e-05	0.000188	CbGpPWpGaD
Topiramate—CA4—Metabolism—INS—atherosclerosis	3.76e-05	0.000187	CbGpPWpGaD
Topiramate—CA9—Metabolism—PPARA—atherosclerosis	3.74e-05	0.000186	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—ALB—atherosclerosis	3.7e-05	0.000184	CbGpPWpGaD
Topiramate—CA2—Metabolism—PPARG—atherosclerosis	3.67e-05	0.000183	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—TGFB1—atherosclerosis	3.66e-05	0.000182	CbGpPWpGaD
Topiramate—CA1—Metabolism—PIK3CG—atherosclerosis	3.65e-05	0.000181	CbGpPWpGaD
Topiramate—CA9—Metabolism—AGT—atherosclerosis	3.63e-05	0.00018	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—AKT1—atherosclerosis	3.62e-05	0.00018	CbGpPWpGaD
Topiramate—CA2—Metabolism—INS—atherosclerosis	3.6e-05	0.000179	CbGpPWpGaD
Topiramate—CA9—Metabolism—APOE—atherosclerosis	3.55e-05	0.000177	CbGpPWpGaD
Topiramate—CA1—Metabolism—PPARG—atherosclerosis	3.52e-05	0.000175	CbGpPWpGaD
Topiramate—CA9—Metabolism—CAV1—atherosclerosis	3.52e-05	0.000175	CbGpPWpGaD
Topiramate—CA9—Metabolism—APOA1—atherosclerosis	3.51e-05	0.000175	CbGpPWpGaD
Topiramate—CA1—Metabolism—INS—atherosclerosis	3.45e-05	0.000172	CbGpPWpGaD
Topiramate—CA4—Metabolism—ALB—atherosclerosis	3.44e-05	0.000171	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—TNF—atherosclerosis	3.42e-05	0.00017	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	3.39e-05	0.000169	CbGpPWpGaD
Topiramate—CA2—Metabolism—ALB—atherosclerosis	3.3e-05	0.000164	CbGpPWpGaD
Topiramate—CA4—Metabolism—NOS3—atherosclerosis	3.29e-05	0.000164	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—ALB—atherosclerosis	3.24e-05	0.000161	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ABCG1—atherosclerosis	3.23e-05	0.000161	CbGpPWpGaD
Topiramate—CA9—Metabolism—PIK3CG—atherosclerosis	3.21e-05	0.00016	CbGpPWpGaD
Topiramate—CA1—Metabolism—ALB—atherosclerosis	3.16e-05	0.000157	CbGpPWpGaD
Topiramate—CA2—Metabolism—NOS3—atherosclerosis	3.16e-05	0.000157	CbGpPWpGaD
Topiramate—CA9—Metabolism—PPARG—atherosclerosis	3.09e-05	0.000154	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—FABP4—atherosclerosis	3.04e-05	0.000151	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—LCAT—atherosclerosis	3.04e-05	0.000151	CbGpPWpGaD
Topiramate—CA9—Metabolism—INS—atherosclerosis	3.03e-05	0.000151	CbGpPWpGaD
Topiramate—CA1—Metabolism—NOS3—atherosclerosis	3.03e-05	0.000151	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	3.01e-05	0.00015	CbGpPWpGaD
Topiramate—CA4—Metabolism—PTGS2—atherosclerosis	3.01e-05	0.00015	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—APOA4—atherosclerosis	2.98e-05	0.000148	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CYP7A1—atherosclerosis	2.93e-05	0.000146	CbGpPWpGaD
Topiramate—CA2—Metabolism—PTGS2—atherosclerosis	2.89e-05	0.000144	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PLTP—atherosclerosis	2.83e-05	0.000141	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	2.79e-05	0.000139	CbGpPWpGaD
Topiramate—CA9—Metabolism—ALB—atherosclerosis	2.78e-05	0.000138	CbGpPWpGaD
Topiramate—CA1—Metabolism—PTGS2—atherosclerosis	2.77e-05	0.000138	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—IL6—atherosclerosis	2.76e-05	0.000137	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CYP27A1—atherosclerosis	2.71e-05	0.000135	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	2.66e-05	0.000133	CbGpPWpGaD
Topiramate—CA9—Metabolism—NOS3—atherosclerosis	2.66e-05	0.000132	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	2.6e-05	0.000129	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ALOX15—atherosclerosis	2.57e-05	0.000128	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PLA2G2A—atherosclerosis	2.57e-05	0.000128	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—APOA2—atherosclerosis	2.57e-05	0.000128	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ALOX5AP—atherosclerosis	2.57e-05	0.000128	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—AKT1—atherosclerosis	2.54e-05	0.000127	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ABCG5—atherosclerosis	2.53e-05	0.000126	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	2.53e-05	0.000126	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ABCG8—atherosclerosis	2.46e-05	0.000122	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—LTA4H—atherosclerosis	2.46e-05	0.000122	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—LPA—atherosclerosis	2.45e-05	0.000122	CbGpPWpGaD
Topiramate—CA9—Metabolism—PTGS2—atherosclerosis	2.43e-05	0.000121	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—BGN—atherosclerosis	2.37e-05	0.000118	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	2.35e-05	0.000117	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—APOA5—atherosclerosis	2.35e-05	0.000117	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	2.28e-05	0.000113	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PLA2G1B—atherosclerosis	2.26e-05	0.000112	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	2.23e-05	0.000111	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	2.21e-05	0.00011	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	2.21e-05	0.00011	CbGpPWpGaD
Topiramate—CA6—Metabolism—AKT1—atherosclerosis	2.19e-05	0.000109	CbGpPWpGaD
Topiramate—CA5A—Metabolism—AKT1—atherosclerosis	2.19e-05	0.000109	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ALOX5—atherosclerosis	2.18e-05	0.000109	CbGpPWpGaD
Topiramate—CA5B—Metabolism—AKT1—atherosclerosis	2.05e-05	0.000102	CbGpPWpGaD
Topiramate—CA7—Metabolism—AKT1—atherosclerosis	2.05e-05	0.000102	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	2.02e-05	0.0001	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—NAMPT—atherosclerosis	1.96e-05	9.73e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.94e-05	9.68e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—LIPC—atherosclerosis	1.94e-05	9.67e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.94e-05	9.66e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—APOC3—atherosclerosis	1.93e-05	9.61e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—LDLR—atherosclerosis	1.92e-05	9.56e-05	CbGpPWpGaD
Topiramate—CA12—Metabolism—AKT1—atherosclerosis	1.9e-05	9.45e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CETP—atherosclerosis	1.88e-05	9.33e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—LCAT—atherosclerosis	1.83e-05	9.08e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—FABP4—atherosclerosis	1.83e-05	9.08e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—SCARB1—atherosclerosis	1.8e-05	8.94e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—APOA4—atherosclerosis	1.79e-05	8.92e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.76e-05	8.76e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.75e-05	8.7e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—HMGCR—atherosclerosis	1.7e-05	8.44e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.63e-05	8.1e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.54e-05	7.68e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.54e-05	7.68e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.54e-05	7.68e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—APOA2—atherosclerosis	1.54e-05	7.68e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.53e-05	7.61e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.52e-05	7.58e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—AKT1—atherosclerosis	1.51e-05	7.53e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ABCA1—atherosclerosis	1.51e-05	7.52e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—LPA—atherosclerosis	1.47e-05	7.32e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—AKT1—atherosclerosis	1.45e-05	7.22e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—BGN—atherosclerosis	1.43e-05	7.09e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—APOA5—atherosclerosis	1.41e-05	7.02e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—AKT1—atherosclerosis	1.39e-05	6.92e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	1.36e-05	6.76e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ALOX5—atherosclerosis	1.31e-05	6.53e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—HMOX1—atherosclerosis	1.3e-05	6.45e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—APOB—atherosclerosis	1.24e-05	6.18e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—AKT1—atherosclerosis	1.22e-05	6.09e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GSTM1—atherosclerosis	1.21e-05	6.01e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—LPL—atherosclerosis	1.19e-05	5.9e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—NAMPT—atherosclerosis	1.18e-05	5.85e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—LIPC—atherosclerosis	1.17e-05	5.82e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—APOC3—atherosclerosis	1.16e-05	5.78e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GPX1—atherosclerosis	1.16e-05	5.76e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—LDLR—atherosclerosis	1.15e-05	5.75e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CETP—atherosclerosis	1.13e-05	5.61e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CD36—atherosclerosis	1.13e-05	5.61e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—SCARB1—atherosclerosis	1.08e-05	5.37e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—MTHFR—atherosclerosis	1.07e-05	5.32e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PPARA—atherosclerosis	1.05e-05	5.21e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—HMGCR—atherosclerosis	1.02e-05	5.08e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—AGT—atherosclerosis	1.01e-05	5.05e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—APOE—atherosclerosis	9.94e-06	4.95e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CAV1—atherosclerosis	9.85e-06	4.9e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—APOA1—atherosclerosis	9.83e-06	4.89e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ABCA1—atherosclerosis	9.09e-06	4.52e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PIK3CG—atherosclerosis	8.97e-06	4.47e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PPARG—atherosclerosis	8.66e-06	4.31e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—INS—atherosclerosis	8.49e-06	4.23e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—HMOX1—atherosclerosis	7.8e-06	3.88e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ALB—atherosclerosis	7.79e-06	3.88e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—APOB—atherosclerosis	7.47e-06	3.72e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—NOS3—atherosclerosis	7.45e-06	3.71e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GSTM1—atherosclerosis	7.27e-06	3.62e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—LPL—atherosclerosis	7.13e-06	3.55e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GPX1—atherosclerosis	6.96e-06	3.46e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PTGS2—atherosclerosis	6.81e-06	3.39e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CD36—atherosclerosis	6.78e-06	3.37e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—MTHFR—atherosclerosis	6.42e-06	3.2e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PPARA—atherosclerosis	6.3e-06	3.14e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—AGT—atherosclerosis	6.1e-06	3.04e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—APOE—atherosclerosis	5.98e-06	2.98e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CAV1—atherosclerosis	5.92e-06	2.95e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—APOA1—atherosclerosis	5.91e-06	2.94e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PIK3CG—atherosclerosis	5.4e-06	2.69e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PPARG—atherosclerosis	5.21e-06	2.59e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—INS—atherosclerosis	5.11e-06	2.54e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ALB—atherosclerosis	4.68e-06	2.33e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—NOS3—atherosclerosis	4.48e-06	2.23e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PTGS2—atherosclerosis	4.1e-06	2.04e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—AKT1—atherosclerosis	3.42e-06	1.7e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—AKT1—atherosclerosis	2.06e-06	1.02e-05	CbGpPWpGaD
